May 20, 2026
1 min read

Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M

Gilead has broadened its partnership with Korean manufacturer Yuhan, agreeing to a $140 million supply deal for active pharmaceutical ingredients for an undisclosed product.

Leave a Reply

Your email address will not be published.

Previous Story

Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference MedNews

Next Story

Sirio unveils nutritional gummies compliant with Australian regulations

Previous Story

Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference MedNews

Next Story

Sirio unveils nutritional gummies compliant with Australian regulations

Latest from Blog

New evidence for ancient cannabis use

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Congratulations on making it to the end of the week. This is Jonathan Wosen,
Go toTop